15th Dec 2016 07:58
LONDON (Alliance News) - Pharmaceuticals and healthcare services company Clinigen Group PLC on Thursday said its Idis Global Access unit has signed a supply and distribution deal with BioQ Pharma, an infusible products maker.
The agreement will cover the on-demand supply and distribution of BioQ's pre-filled Ropivacaine Readyfusor for post-operative pain management in Europe, excluding France and Germany.
No financial details on the contract were disclosed.
By Sam Unsted; [email protected]; @SamUAtAlliance
Copyright 2016 Alliance News Limited. All Rights Reserved.
Related Shares:
CLIN.L